Picture of Collegium Pharmaceutical logo

COLL — Collegium Pharmaceutical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Brief: Collegium Reports Third Quarter 2022 Financial Results

Nov 3 (Reuters) - Collegium Pharmaceutical Inc  COLL.O :
    * COLLEGIUM REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
    * Q3 REVENUE $127.0 MILLION
    * UPDATED FULL YEAR 2022 GUIDANCE
    * SEES 2022 TOTAL PRODUCT REVENUE IN THE RANGE OF $455
MILLION TO
$465 MILLION
    * QTRLY GAAP EPS OF $0.01
    * QTRLY ADJUSTED EARNINGS PER SHARE OF $1.10
    * Q3 EARNINGS PER SHARE VIEW $-0.14, REVENUE VIEW $124.3
MILLION
-- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX555GsQ 
Further company coverage:  COLL.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Collegium Pharmaceutical

See all news